Attenuated influenza virions expressing the SARS-CoV-2 receptor-binding domain induce neutralizing antibodies in mice

Mostrar otras versiones (1)

An effective vaccine is essential to controlling the spread of SARS-CoV-2 virus. Here, we describe an influenza-virus-based vaccine for SARS-CoV-2. We incorporated a membrane-anchored form of the SARS-CoV-2 Spike receptor binding domain (RBD) in place of the neuraminidase (NA) coding sequence in an...

Descripción completa

Detalles Bibliográficos
Autores principales: Loes, Andrea N., Gentles, Lauren E., Greaney, Allison J., Crawford, Katharine H. D., Bloom, Jesse D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430565/
https://www.ncbi.nlm.nih.gov/pubmed/32817935
http://dx.doi.org/10.1101/2020.08.12.248823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430565/
https://www.ncbi.nlm.nih.gov/pubmed/32817935
http://dx.doi.org/10.1101/2020.08.12.248823

Ejemplares similares